---
title: "VERA.US (VERA.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/VERA.US/news.md"
symbol: "VERA.US"
name: "VERA.US"
parent: "https://longbridge.com/en/quote/VERA.US.md"
datetime: "2026-05-20T12:12:09.248Z"
locales:
  - [en](https://longbridge.com/en/quote/VERA.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/VERA.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/VERA.US/news.md)
---

# VERA.US (VERA.US) — Related News

### [UBS Group AG Boosts Position in Vera Therapeutics, Inc. $VERA](https://longbridge.com/en/news/286643383.md)
*2026-05-16T10:57:20.000Z*
> UBS Group AG increased its stake in Vera Therapeutics, Inc. (NASDAQ:VERA) by 27.9% in Q4, owning 207,289 shares valued a

### [Vera Therapeutics: Buy Rating Reiterated on Strong Atacicept Outlook and Launch Readiness; $73 Price Target Maintained](https://longbridge.com/en/news/285662461.md)
*2026-05-08T04:07:04.000Z*
> Analyst Ritu Baral from TD Cowen has reiterated a Buy rating on Vera Therapeutics, maintaining a price target of $73. Th

### [Vera Therapeutics (NASDAQ:VERA) Posts Quarterly Earnings Results, Misses Expectations By $0.36 EPS](https://longbridge.com/en/news/285655953.md)
*2026-05-08T03:05:22.000Z*
> Vera Therapeutics (NASDAQ:VERA) reported quarterly earnings of ($1.69) EPS, missing the consensus estimate of ($1.33) by

### [Vera Therapeutics (VERA) Gets a Buy from LifeSci Capital](https://longbridge.com/en/news/285608009.md)
*2026-05-07T19:55:25.000Z*
> LifeSci Capital analyst Rami Katkhuda has maintained a Buy rating on Vera Therapeutics (VERA) with a price target of $90

### [Vera Therapeutics | 8-K: FY2026 Q1 Revenue: USD 0](https://longbridge.com/en/news/285541707.md)
*2026-05-07T11:33:03.000Z*
### [New Verana Health AI Agent Boosts Efficiency and Compliance in MIPS Submissions](https://longbridge.com/en/news/284404568.md)
*2026-04-28T13:52:16.000Z*
> Agent Claire is enabling clinicians to make quicker decisions, lower risk, and enhance operational efficiency. On April 

### [AMI Asset Management Corp Makes New $1.44 Million Investment in Vera Therapeutics, Inc. $VERA](https://longbridge.com/en/news/282644785.md)
*2026-04-14T07:12:22.000Z*
> AMI Asset Management Corp has invested $1.44 million in Vera Therapeutics, acquiring 28,523 shares. Other institutional